On the money.
The current price suggests that FY22 will be negative or equal to FY21, with little to no growth occurring in FY23.
Based on This Years Estmates
NPAT = 28m
EPS = 28/62.27 = 0.449
PE = 8.67
In reality the MCAP should be 350m to 380m and price between $5.62 to $6.1, PE~13. But who knows why Mr Market does what he does.
If you bought in low $2, the dividends are quite amazing.
- Forums
- ASX - By Stock
- DSK
- DSK valuation
DSK valuation, page-2
Featured News
Add DSK (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $74.72M |
Open | High | Low | Value | Volume |
$1.20 | $1.20 | $1.15 | $126.4K | 108.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6900 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 1536 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6900 | 1.170 |
1 | 16586 | 1.155 |
1 | 15000 | 1.150 |
1 | 381 | 1.135 |
5 | 8509 | 1.130 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 1536 | 3 |
1.210 | 42132 | 3 |
1.220 | 40000 | 1 |
1.240 | 15896 | 3 |
1.250 | 21000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DSK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online